We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Microarrays Used for Blood Typing and Infectious Disease Diagnosis

By LabMedica International staff writers
Posted on 06 May 2009
Multiplex microarray assays are being developed to accelerate routine blood typing and the diagnosis of infectious diseases.

Scientists from the University of Edinburgh (Edinburgh, UK) are developing microarray technology and assays specifically to improve the understanding and diagnosis of infectious diseases, especially those caused by herpes viruses or human immunodeficiency virus (HIV). More...
They are using Tecan's (Männedorf, Switzerland) LS Reloaded laser scanner for automated scanning of both microplates and slides.

Dr. Colin Campbell, an investigator at the university, explained, "Our LS Reloaded scanner gives us the level of versatility that we need for assay development that other scanners could not provide. For example, the scanner allows a high degree of flexibility with a choice of materials and chip geometries so that we can scan from underneath or above, and can use silicon wafers and nonstandard chip sizes."

The Edinburgh scientists recently developed a microarray-based assay for ABO and Rhesus blood group typing, and are now developing this further to bring all the pretransfusion testing for other blood groups and infectious diseases together on one microarray. Dr. Campbell commented, "Our ultimate aim is to develop a single microarray-based test that will include all the critical antigens that must be matched for a successful blood transfusion to take place."

Tecan is a global supplier of laboratory instruments and solutions for the biopharma, forensic, and diagnostic industries. The company specializes in the development, production, and distribution of automation solutions for life science laboratories. Tecan's clients include pharmaceutic and biotech companies, university research departments, diagnostic laboratories and companies, as well as forensics laboratories. The company has production, research, and development sites in both North America and Europe and maintains a sales and service network in 52 countries.

Related Links:

University of Edinburgh
Tecan


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hematology Consumables
Bioblood Devices
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.